Thirty-One-Day Target: Drug Therapy as a Subsequent Treatment
Thirty-One-Day Target: Drug Therapy as a Subsequent TreatmentA cancer target (standard) promulgated by the NHS as of 2009, which requires that all subsequent drug treatments (not just first definitive treatment) are subject to a 3- day standard (target—i.e., the patient receiving adjuvant chemotherapy post-surgery) and must receive the therapy (e.g., hormonal or chemo) within 31 days of the decision to treat has been made. As with the other post-2009 targets, the cancer care team cannot adjust for patient non-attendance (did not attend—DNA), patient cancellation or medical suspension. Pauses (“stopping the clock”) are only allowed for patients being treated electively (i.e., as an inpatient or day case).
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.